Published in Ann Hematol on October 01, 1996
Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost (1997) 1.43
The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost (1997) 1.00
Frequencies of platelet-specific alloantigen systems 1-5 in three distinct ethnic groups in Brazil. Eur J Immunogenet (1999) 0.95
Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost (2000) 0.93
Prevalence of the mutation C677 --> T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet (1998) 0.90
Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost (1997) 0.89
Factor V Leiden (FVQ 506) is common in a Brazilian population. Am J Hematol (1995) 0.88
[Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology]. Arq Bras Cardiol (2013) 0.86
Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol (1998) 0.85
The human platelet alloantigen 5 polymorphism as a risk for the development of acute idiopathic thrombocytopenia purpura. Thromb Haemost (2000) 0.84
Novel insights into the development of atherosclerosis in hemophilia A mouse models. J Thromb Haemost (2011) 0.83
Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang (2004) 0.81
Prevalence of the prothrombin gene variant 20210 G --> A among patients with myocardial infarction. Cardiovasc Res (1998) 0.80
Eleven novel mutations in the factor VIII gene from Brazilian hemophilia A patients. Blood (1995) 0.80
Determination of the frequency of the 35delG allele in Brazilian neonates. Clin Genet (2000) 0.80
High frequency of vitamin B12 deficiency in a Brazilian population. Public Health Nutr (2010) 0.78
Evaluation of the host response to endotoxemia of FVIII and FIX deficient mice. Haemophilia (2011) 0.78
Rapid detection of the prothrombin C20209T variant by differential sensitivity to restriction endonuclease digestion. J Thromb Haemost (2003) 0.78
Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease. J Pediatr Orthop (1999) 0.77
Inherited risk factors for thrombophilia in children with nephrotic syndrome. Eur J Pediatr (1998) 0.77
Use of autologous fibrin glue in dermatologic surgery: application of skin graft and second intention healing. Sao Paulo Med J (1999) 0.76
Hemostasis in blood donors with hepatitis C virus. Haemostasis (1994) 0.75
Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden. Platelets (2009) 0.75
Allelic frequencies of three VNTRs in intron 40 of the human von Willebrand factor gene in types 1, 2, and 3 von Willebrand disease patients and controls of a Brazilian population. Thromb Res (2000) 0.75
[Detection of hemophilia A gene carriers in a Brazilian population]. Rev Assoc Med Bras (1994) 0.75
A novel nonsense mutation 6, E - X in the protein S gene causes type I deficiency. Hum Hered (1999) 0.75
Determination of the allele frequencies of three polymorphisms in the promoter region of the human protein C gene in three Brazilian ethnic groups. Hum Hered (1999) 0.75
Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients. J Hum Genet (2007) 0.75
Very low incidence of Arg506-->Gin mutation in the factor V gene among the Amazonian Indians and the Brazilian black population. Thromb Haemost (1996) 0.75
Study of hemostasis in pediatric patients with portal vein thrombosis. Haematologica (1998) 0.75
Performance of a point-of-care device in determining prothrombin time in supra-therapeutic INRs. Int J Lab Hematol (2012) 0.75
Antithrombin deficiency in Brazilian patients with venous thrombosis: molecular characterization of a single splice site mutation, an insertion and a de novo point mutation. Thromb Res (2001) 0.75
The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis. Blood Coagul Fibrinolysis (2000) 0.75
Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus. Sangre (Barc) (1998) 0.75
A novel splice site mutation in a Brazilian patient with hereditary antithrombin deficiency type I. Hum Hered (1999) 0.75